| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $11,750 | +16 | +0.03% | $727.20 | 54,284 | 18 Nov 2024 | Direct | F1 |
| transaction | LLY | Common Stock | Award | $220,000 | +303 | +0.56% | $727.20 | 54,586 | 18 Nov 2024 | Direct |
| Id | Content |
|---|---|
| F1 | At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. |